These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9764413)

  • 41. DNA adduct formation by the anticancer drug ellipticine in rats determined by 32P postlabeling.
    Stiborová M; Breuer A; Aimová D; Stiborová-Rupertová M; Wiessler M; Frei E
    Int J Cancer; 2003 Dec; 107(6):885-90. PubMed ID: 14601046
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of DNA double-strand breaks by 8-methoxycaffeine: cell cycle dependence and comparison with topoisomerase II inhibitors.
    Russo P; Cimoli G; Valenti M; De Sessa F; Parodi S; Pommier Y
    Carcinogenesis; 1994 Nov; 15(11):2491-6. PubMed ID: 7955097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells.
    Poljaková J; Eckschlager T; Hrabeta J; Hrebacková J; Smutný S; Frei E; Martínek V; Kizek R; Stiborová M
    Biochem Pharmacol; 2009 May; 77(9):1466-79. PubMed ID: 19426684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanism of cytotoxicity of N-[2-(dimethylamino)ethyl] acridine-4-carboxamide and of its 7-chloro derivative: the roles of topoisomerases I and II.
    Bridewell DJ; Finlay GJ; Baguley BC
    Cancer Chemother Pharmacol; 1999; 43(4):302-8. PubMed ID: 10071981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cellular uptake as a determinant of cytotoxicity of quaternized ellipticines to human brain tumor cells.
    Vistica DT; Kenney S; Hursey ML; Boyd MR
    Biochem Biophys Res Commun; 1994 May; 200(3):1762-8. PubMed ID: 8185636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and antiproliferative activity of some ellipticine-like 11H-pyrido[a]carbazole derivatives.
    Ferlin MG; Gia O; Dalla Via L
    ChemMedChem; 2011 Oct; 6(10):1872-83. PubMed ID: 21826796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of topoisomerases II alpha and beta in Chinese hamster lung cells resistant to topoisomerase II inhibitors.
    Khélifa T; Casabianca-Pignède MR; René B; Jacquemin-Sablon A
    Mol Pharmacol; 1994 Aug; 46(2):323-8. PubMed ID: 8078494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The 1'-substituent on the anilino ring of the antitumor drug amsacrine is a critical element for topoisomerase II inhibition and cytotoxicity.
    Rene B; Fosse P; Khelifa T; Jacquemin-Sablon A; Bailly C
    Mol Pharmacol; 1996 Feb; 49(2):343-50. PubMed ID: 8632768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radiation hypersensitivity of LEC strain rats controlled by a single autosomal recessive gene.
    Hayashi M; Okui T; Endoh D; Sato F; Kasai N; Namioka S
    Mutat Res; 1994 Mar; 314(2):135-42. PubMed ID: 7510363
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Azatoxin is a mechanistic hybrid of the topoisomerase II-targeted anticancer drugs etoposide and ellipticine.
    Cline SD; Macdonald TL; Osheroff N
    Biochemistry; 1997 Oct; 36(42):13095-101. PubMed ID: 9335572
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma.
    Poljakova J; Hrebackova J; Dvorakova M; Moserova M; Eckschlager T; Hrabeta J; Göttlicherova M; Kopejtkova B; Frei E; Kizek R; Stiborova M
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():101-16. PubMed ID: 22167207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Teratogenic effects of 9-hydroxy-ellipticine in mouse embryo].
    Cros S; Raynaud A
    C R Seances Acad Sci III; 1982 Oct; 295(7):465-70. PubMed ID: 6819062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypersensitivity of LEC strain rats in radiation-induced acute bone-marrow death.
    Hayashi M; Endoh D; Kon Y; Yamashita T; Sato F; Kasai N; Namioka S
    J Vet Med Sci; 1993 Feb; 55(1):13-8. PubMed ID: 8461407
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression.
    Giaccone G; Gazdar AF; Beck H; Zunino F; Capranico G
    Cancer Res; 1992 Apr; 52(7):1666-74. PubMed ID: 1312895
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: structure-activity relationship.
    Fossé P; René B; Charra M; Paoletti C; Saucier JM
    Mol Pharmacol; 1992 Oct; 42(4):590-5. PubMed ID: 1331751
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxidation of an antitumor drug ellipticine by peroxidases.
    Poljaková J; Forsterová K; Sulc M; Frei E; Stiborová M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):449-53. PubMed ID: 16601808
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antifolates can potentiate topoisomerase II inhibitors in vitro and in vivo.
    Holden SA; Teicher BA; Robinson MF; Northey D; Rosowsky A
    Cancer Chemother Pharmacol; 1995; 36(2):165-71. PubMed ID: 7767954
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytotoxicity and topoisomerase I/II inhibition activity of novel 4-aryl/alkyl-1-(piperidin-4-yl)-carbonylthiosemicarbazides and 4-benzoylthiosemicarbazides.
    Siwek A; Bielawska A; Maciorkowska E; Lepiarczyk M; Bielawski K; Trotsko N; Wujec M
    J Enzyme Inhib Med Chem; 2014 Apr; 29(2):243-8. PubMed ID: 23432612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Cellular resistance to DNA-topoisomerase II inhibitors].
    Jacquemin-Sablon A; Bojanowski K; Casabianca-Pignède MR; Crémier S; Delaporte C; Khelifa T; Markovits J; René B; Saucier JM; Larsen AK
    Bull Cancer; 1994 May; 81(5):381-5. PubMed ID: 7749214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytochrome P450- and peroxidase-mediated oxidation of anticancer alkaloid ellipticine dictates its anti-tumor efficiency.
    Stiborová M; Rupertová M; Frei E
    Biochim Biophys Acta; 2011 Jan; 1814(1):175-85. PubMed ID: 20576524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.